Table 3.
Correlation of microproteinuria and creatinine clearance of IBD patients after 5-ASA treatment (mean±SE)
|
Ulcerative colitis (n=194)
5-ASA treatment |
P |
Crohn's disease (n=83)
5-ASA treatment |
P | |||
| No (n=37) | Yes (n=157) | No (n=15) | Yes (n=68) | |||
| Urine m-ALB (μg/min) | 8.99 ± 2.10 | 9.90 ± 1.29 | 0.794 | 8.08 ± 2.57 | 7.13 ± 1.08 | 0.562 |
| Urine β2mGLB (μg/min) | 163 ± 61.16 | 107 ± 12.07 | 0.852 | 274 ± 129.2 | 111.0 ± 20.15 | 0.083 |
| Urine β-NAG (U/L) | 4.22 ± 0.82 | 2.67 ± 0.18 | 0.118 | 2.79 ± 0.91 | 2.42 ± 0.26 | 0.845 |
| Urine Kcr (mL/min) | 117 ± 7.25 | 119 ± 3.11 | 0.987 | 130 ± 7.62 | 129 ± 4.05 | 0.713 |